Myotonic Muscle Activity Drives a Persistent Pain State Responsive to NaV1.8-directed Analgesics.
These findings establish a link between myotonia and persistent alterations in nociceptive processing and identify NaV1.8-directed analgesia as a promising therapeutic strategy for myotonia-associated pain.